Risk of atypical femoral fracture higher with longer duration of bisphosphonate use and in other groups of women
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Risk of Atypical Femoral Fracture Higher With Longer Duration of Bisphosphonate Use and in Other Groups of Women." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315180/0/grapherence/d1315180.
Risk of atypical femoral fracture higher with longer duration of bisphosphonate use and in other groups of women. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315180/0/grapherence/d1315180. Accessed April 28, 2024.
Risk of atypical femoral fracture higher with longer duration of bisphosphonate use and in other groups of women. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315180/0/grapherence/d1315180
Risk of Atypical Femoral Fracture Higher With Longer Duration of Bisphosphonate Use and in Other Groups of Women [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 April 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315180/0/grapherence/d1315180.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risk of atypical femoral fracture higher with longer duration of bisphosphonate use and in other groups of women
ID - 1315180
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315180/0/grapherence/d1315180
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -